TokenPost topic
1 TokenPost story is tagged Vir Biotechnology. The newest appear first.
Gilead will use Vir’s PRO-XTEN platform to discover and develop cancer drugs under an agreement valued at up to nearly $1.9 billion.
Oct 14, 2026, 9:15 AM EDT · Business